| Cell line name |
HRA |
|---|
| Accession |
CVCL_U986 |
|---|
| Resource Identification Initiative |
To cite this cell line use: HRA (RRID:CVCL_U986) |
|---|
| Comments |
Population: Japanese.
Doubling time: 15.6 hours (PubMed=3791243).
Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. |
|---|
| Disease |
Ovarian serous cystadenocarcinoma (NCIt: C7978) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_ZE74 (HR) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=3791243
Yoshihiro Kikuchi, Isao Kizawa, Keibun Oomori, Munenori Miyauchi, Tsunekazu Kita, Michio Sugita, Yoshio Tenjin, Koichi Kato;
Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation.
Cancer Res. 47:592-596(1987) PubMed=10381137; DOI=10.1016/S0304-3835(98)00270-5
Hiroho Ohta, Hideki Sakamoto, Kazuo Satoh;
In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum.
Cancer Lett. 134:111-118(1998) PubMed=12019149
Hiroaki Kajiyama, Fumitaka Kikkawa, Takahiro Suzuki, Kiyosumi Shibata, Kazuhiko Ino, Shigehiko Mizutani;
Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma.
Cancer Res. 62:2753-2757(2002) PubMed=18720132; DOI=10.1080/10717540802329183
Takehiro Serikawa, Hiroshi Kikuchi, Takashi Oite, Kenichi Tanaka;
Enhancement of gene expression efficiency using cationic liposomes on ovarian cancer cells.
Drug Deliv. 15:523-529(2008) |
|---|
| Cross-references |
|---|
| Anatomy/cell type resources |
BTO; BTO_0004925
|
|---|
| Encyclopedic resources |
Wikidata; Q54895212
|
|---|
| Entry history |
|---|
| Entry creation | 16-Apr-2014 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 8 |
|---|
